Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$7.61 -0.17 (-2.12%)
As of: Oct 23, 2026 · 1:28 PM EDT

Biocryst Pharmaceuticals (BCRX) Short-Term Debt repayments (2018 - 2020)

Updated

Biocryst Pharmaceuticals (BCRX) reported Short-Term Debt repayments of $47.42 million for Q4 2020.

Analysis

Biocryst Pharmaceuticals (BCRX) Short-Term Debt repayments (2018 - 2020) Analysis & Trends

For FY2020, Biocryst Pharmaceuticals posted Short-Term Debt repayments of $52.42 million.

  • By year, Short-Term Debt repayments came in at $4.03 million in FY2018.
  • The Q4 2020 figure ranks as the lowest quarterly Short-Term Debt repayments since Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,138.00 Bn 1,106.58 Bn 19.71 Bn -
2 Johnson & Johnson 634.40 Bn 554.26 Bn 17.30 Bn 6.63 Bn
3 AbbVie 506.36 Bn 479.47 Bn 12.70 Bn -
4 Merck 358.30 Bn 312.68 Bn 12.21 Bn -
5 Novartis Ag 293.12 Bn 257.11 Bn 11.24 Bn -
6 Astrazeneca 265.36 Bn 239.05 Bn 12.86 Bn -
7 Amgen 238.40 Bn 193.80 Bn 7.24 Bn -
8 Gilead Sciences 195.15 Bn 169.35 Bn 6.22 Bn -
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn -
10 Biocryst Pharmaceuticals 1.94 Bn 859.28 Mn 214.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 47.42 Mn
Sep 30, 2018 575,000.00
Jun 30, 2018 1.73 Mn
Mar 31, 2018 1.73 Mn
API Access

Biocryst Pharmaceuticals Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=BCRX&period=max&api_key=YOUR_API_KEY